Clinical Trial Update: Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial updating treatment of atherosclerotic disease using paclitaxel-associated LDL-like nanoparticles; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• paclitaxel-associated LDL-like nanoparticles (paclitaxel-associated LDL-like nanoparticles)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Coronary Artery Disease, Atherosclerosis | Phase 2, Phase 3 | Status: UNKNOWN